Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18F2N2O2 |
InChIKeyYUYJEQHNWKQNBT-UHFFFAOYSA-N |
CAS Registry1627709-94-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 11 May 2014 |